Healthcare / Medical Care FacilitiesThailand
$12.50
-0.70 (-5.30%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 24% · confianza 25%
FCF escenarios
weak_data · normalized FCF $154.0M · quality 79.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
48/100
C
Piotroski
5/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$1.9B
P/E
14.7x
↓EV/EBITDA
5.9x
↓ROE
7.1%
↑Gross Margin
20.9%
↓Debt/Equity
0.00
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-2.7%
FCF CAGR
-8.1%
FCF margin
8.7%
FCF / Net income
1.02x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.80B · net income $153.7M · FCF $156.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.80B | $1.80B | $1.76B | $1.79B | $1.96B |
| Net Income | $153.7M | $153.7M | $127.0M | $188.8M | $271.1M |
| EBITDA | $280.4M | $280.4M | $242.0M | $309.4M | $409.3M |
| EPS | — | — | 0.85 | 1.26 | 1.81 |
| Gross Margin | 20.9% | 20.9% | 18.5% | 23.4% | 26.5% |
| Operating Margin | 8.3% | 8.3% | 6.3% | 11.1% | 15.8% |
| Net Margin | 8.5% | 8.5% | 7.2% | 10.5% | 13.8% |
| Balance Sheet | |||||
| Debt/Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 6.54 | 6.54 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $156.7M | $156.7M | $104.8M | $154.0M | $201.8M |
| Returns | |||||
| ROE | 7.1% | 7.1% | 6.1% | 9.1% | 13.1% |
| Valuation | |||||
| P/E | 14.71 | 14.71 | 18.45 | 13.65 | 9.72 |
| EV/EBITDA | 5.90 | 5.90 | 8.70 | 7.67 | 6.01 |
| P/B | 0.87 | 0.87 | 1.12 | 1.24 | 1.28 |
| Growth & Yield | |||||
| Revenue Growth | 2.6% | 2.6% | -2.0% | -8.5% | — |
| EPS Growth | — | — | -32.5% | -30.4% | — |
| Dividend Yield | 3.9% | 3.9% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-6.8%
Start / end P/E
n/dx → n/dx
EPS bridge
0.85 → n/d
Residual
-10.7%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.